Amgen, Pfizer’s Hospira Settle Neulasta Cancer Drug Patent Suit – Bloomberg Law

Amgen Inc. and Pfizer Inc.’s Hospira settled a patent-infringement lawsuit over Hospira’s proposed biosimilar version of Neulasta, the blockbuster …